Chronic amphotericin B nephrotoxicity in the rat: Protective effect of calcium channel blockade

Jonathan P. Tolins, Leopoldo Raij

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Amphotericin B is used despite predictable nephrotoxicity because it remains the most efficacious agent currently available for systemic fungal infections. It has been previously shown that calcium channel blockade prevents renal vasoconstriction and blunts the fall in glomerular filtration rate during acute amphotericin B infusion in the rat. Therefore, the effect of cotreatment with diltiazem on nephrotoxicity during chronic daily amphotericin therapy in rats was studied. Rats were given diltiazem (45 mg/ kg, 1 h before and 1 h after amphotericin) or vehicle by gastric tube; and amphotericin B (5 mg/kg/day i.p.)for 10 days. Control rats received corresponding vehicles by gastric tube and daily i.p. infection. Renal function was determined 24 h after the last dose of amphotericin or vehicle. Serum creatinine rose significantly in rats receiving amphotericin alone (initial versus final, 0.50 ± 0.07 versus 1.09 ± 0.20 mg/dL; P < 0.05) but not with amphotericin plus diltiazem (0.54 ± 0.11 versus 0.84 ± 0.23 mg/dL; P was not significant). Amphotericin rats had a marked decrease in glomerular filtration rate (amphotericin versus control, 0.28 ± 0.04 versus 1.23 ± 0.08 mL/ min/g kidney wt; P < 0.05) and renal plasma flow (1.63 ± 0.19 versus 3.50 ± 0.40 mL/min/g kidney wt; P < 0.05). These adverse renal hemodynamic effects were prevented by cotreatment with diltiazem (amphotericin plus diltiazem; glomerular filtration rate, 0.82 ± 0.18 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control; renal plasma flow, 3.24 ± 0.63 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control). In summary, cotreatment with diltiazem ameliorated amphotericin B-induced rise in creatinine, fall in glomerular filtration rate and fall in renal plasma flow. It was concluded that calcium channel blockade preserves renal function during chronic daily amphotericin B therapy in the rat.

Original languageEnglish
Pages (from-to)98-102
Number of pages5
JournalJournal of the American Society of Nephrology
Volume2
Issue number1
StatePublished - Jul 1 1991
Externally publishedYes

Fingerprint

Amphotericin B
Calcium Channels
Diltiazem
Kidney
Renal Plasma Flow
Glomerular Filtration Rate
Creatinine
Stomach
Mycoses
Vasoconstriction

Keywords

  • Amphotericin B
  • Calcium channel blockade
  • Diltiazem
  • Nephrotoxicity

ASJC Scopus subject areas

  • Nephrology

Cite this

Chronic amphotericin B nephrotoxicity in the rat : Protective effect of calcium channel blockade. / Tolins, Jonathan P.; Raij, Leopoldo.

In: Journal of the American Society of Nephrology, Vol. 2, No. 1, 01.07.1991, p. 98-102.

Research output: Contribution to journalArticle

@article{d4576f0f944e4b3f83b00a6847e9b7dd,
title = "Chronic amphotericin B nephrotoxicity in the rat: Protective effect of calcium channel blockade",
abstract = "Amphotericin B is used despite predictable nephrotoxicity because it remains the most efficacious agent currently available for systemic fungal infections. It has been previously shown that calcium channel blockade prevents renal vasoconstriction and blunts the fall in glomerular filtration rate during acute amphotericin B infusion in the rat. Therefore, the effect of cotreatment with diltiazem on nephrotoxicity during chronic daily amphotericin therapy in rats was studied. Rats were given diltiazem (45 mg/ kg, 1 h before and 1 h after amphotericin) or vehicle by gastric tube; and amphotericin B (5 mg/kg/day i.p.)for 10 days. Control rats received corresponding vehicles by gastric tube and daily i.p. infection. Renal function was determined 24 h after the last dose of amphotericin or vehicle. Serum creatinine rose significantly in rats receiving amphotericin alone (initial versus final, 0.50 ± 0.07 versus 1.09 ± 0.20 mg/dL; P < 0.05) but not with amphotericin plus diltiazem (0.54 ± 0.11 versus 0.84 ± 0.23 mg/dL; P was not significant). Amphotericin rats had a marked decrease in glomerular filtration rate (amphotericin versus control, 0.28 ± 0.04 versus 1.23 ± 0.08 mL/ min/g kidney wt; P < 0.05) and renal plasma flow (1.63 ± 0.19 versus 3.50 ± 0.40 mL/min/g kidney wt; P < 0.05). These adverse renal hemodynamic effects were prevented by cotreatment with diltiazem (amphotericin plus diltiazem; glomerular filtration rate, 0.82 ± 0.18 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control; renal plasma flow, 3.24 ± 0.63 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control). In summary, cotreatment with diltiazem ameliorated amphotericin B-induced rise in creatinine, fall in glomerular filtration rate and fall in renal plasma flow. It was concluded that calcium channel blockade preserves renal function during chronic daily amphotericin B therapy in the rat.",
keywords = "Amphotericin B, Calcium channel blockade, Diltiazem, Nephrotoxicity",
author = "Tolins, {Jonathan P.} and Leopoldo Raij",
year = "1991",
month = "7",
day = "1",
language = "English",
volume = "2",
pages = "98--102",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Chronic amphotericin B nephrotoxicity in the rat

T2 - Protective effect of calcium channel blockade

AU - Tolins, Jonathan P.

AU - Raij, Leopoldo

PY - 1991/7/1

Y1 - 1991/7/1

N2 - Amphotericin B is used despite predictable nephrotoxicity because it remains the most efficacious agent currently available for systemic fungal infections. It has been previously shown that calcium channel blockade prevents renal vasoconstriction and blunts the fall in glomerular filtration rate during acute amphotericin B infusion in the rat. Therefore, the effect of cotreatment with diltiazem on nephrotoxicity during chronic daily amphotericin therapy in rats was studied. Rats were given diltiazem (45 mg/ kg, 1 h before and 1 h after amphotericin) or vehicle by gastric tube; and amphotericin B (5 mg/kg/day i.p.)for 10 days. Control rats received corresponding vehicles by gastric tube and daily i.p. infection. Renal function was determined 24 h after the last dose of amphotericin or vehicle. Serum creatinine rose significantly in rats receiving amphotericin alone (initial versus final, 0.50 ± 0.07 versus 1.09 ± 0.20 mg/dL; P < 0.05) but not with amphotericin plus diltiazem (0.54 ± 0.11 versus 0.84 ± 0.23 mg/dL; P was not significant). Amphotericin rats had a marked decrease in glomerular filtration rate (amphotericin versus control, 0.28 ± 0.04 versus 1.23 ± 0.08 mL/ min/g kidney wt; P < 0.05) and renal plasma flow (1.63 ± 0.19 versus 3.50 ± 0.40 mL/min/g kidney wt; P < 0.05). These adverse renal hemodynamic effects were prevented by cotreatment with diltiazem (amphotericin plus diltiazem; glomerular filtration rate, 0.82 ± 0.18 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control; renal plasma flow, 3.24 ± 0.63 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control). In summary, cotreatment with diltiazem ameliorated amphotericin B-induced rise in creatinine, fall in glomerular filtration rate and fall in renal plasma flow. It was concluded that calcium channel blockade preserves renal function during chronic daily amphotericin B therapy in the rat.

AB - Amphotericin B is used despite predictable nephrotoxicity because it remains the most efficacious agent currently available for systemic fungal infections. It has been previously shown that calcium channel blockade prevents renal vasoconstriction and blunts the fall in glomerular filtration rate during acute amphotericin B infusion in the rat. Therefore, the effect of cotreatment with diltiazem on nephrotoxicity during chronic daily amphotericin therapy in rats was studied. Rats were given diltiazem (45 mg/ kg, 1 h before and 1 h after amphotericin) or vehicle by gastric tube; and amphotericin B (5 mg/kg/day i.p.)for 10 days. Control rats received corresponding vehicles by gastric tube and daily i.p. infection. Renal function was determined 24 h after the last dose of amphotericin or vehicle. Serum creatinine rose significantly in rats receiving amphotericin alone (initial versus final, 0.50 ± 0.07 versus 1.09 ± 0.20 mg/dL; P < 0.05) but not with amphotericin plus diltiazem (0.54 ± 0.11 versus 0.84 ± 0.23 mg/dL; P was not significant). Amphotericin rats had a marked decrease in glomerular filtration rate (amphotericin versus control, 0.28 ± 0.04 versus 1.23 ± 0.08 mL/ min/g kidney wt; P < 0.05) and renal plasma flow (1.63 ± 0.19 versus 3.50 ± 0.40 mL/min/g kidney wt; P < 0.05). These adverse renal hemodynamic effects were prevented by cotreatment with diltiazem (amphotericin plus diltiazem; glomerular filtration rate, 0.82 ± 0.18 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control; renal plasma flow, 3.24 ± 0.63 mL/min/g kidney wt; P < 0.05 versus amphotericin; P was not significant versus control). In summary, cotreatment with diltiazem ameliorated amphotericin B-induced rise in creatinine, fall in glomerular filtration rate and fall in renal plasma flow. It was concluded that calcium channel blockade preserves renal function during chronic daily amphotericin B therapy in the rat.

KW - Amphotericin B

KW - Calcium channel blockade

KW - Diltiazem

KW - Nephrotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0026195956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026195956&partnerID=8YFLogxK

M3 - Article

C2 - 1912413

AN - SCOPUS:0026195956

VL - 2

SP - 98

EP - 102

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 1

ER -